Effects of Menthacarin on symptoms and quality of life in patients with functional dyspepsia: Result of a 8-week optional placebo controlled follow-up

Introduction: Functional dyspepsia (FD) and irritable bowel syndrome (IBS) are common functional gastrointestinal disorders affecting more than 10% of the populations. While a previous 4-week randomised, placebo controlled trial in patients with FD demonstrated a beneficial effect of Menthacarin* in relation to the improvement of FD symptoms1, very little is known about the long term treatment effects. Thus we report results of a 8-week follow-up of patients who had completed a double-blind study, and who agreed an optional continuation treatment according to the initial randomisation. Material and methods: The…